< Back to titles
> Cover Page, Authors, Institutions
> Purpose/Objective
> Materials/Methods
> Results
> Conclusions
> View additional images/videos
|
|
Conclusions:
This study suggests that subconjuncival bevacizumab administration inhibited corneal NV and bevacizumab attenuates VEGF-induced angiogenesis. This agent may prove useful in the treatment of corneal angiogenic disorders.
|
|
